Llwytho...
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Neuroblastoma, an embryonal tumor of the peripheral sympathetic nervous system, accounts for approximately 15% of all deaths due to childhood cancer1. High-risk neuroblastomas, prevalent in the majority of patients, are rapidly progressive; even with intensive myeloablative chemotherapy, relapse is...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
2008
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2587486/ https://ncbi.nlm.nih.gov/pubmed/18923525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature07397 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|